HomeNewsOpinionCOVID-19 pandemic | Why Kerala’s Rs 20,000 crore relief package is not financial wizardry

COVID-19 pandemic | Why Kerala’s Rs 20,000 crore relief package is not financial wizardry

With its third consecutive state-wide crisis, Kerala is at its wits end. There is a limit to what the state can do, and we will be in a serious crisis if the Centre does not help, writes Kerala Finance Minister Thomas Isaac.

March 25, 2020 / 08:39 IST
Story continues below Advertisement
Representative image
Representative image

Thomas Isaac

In recent days, especially since the Government of Kerala announced a Rs 20,000 crore financial package to revive the state’s economy, I’ve been hearing questions about how the state can bring out such a package, is it implementable, can similar models be replicated, and, what role can the Centre play in this?

Story continues below Advertisement

There is no financial window dressing or skulduggery here, but a bit of innovation — the type we’re forced to take when push comes to shove. At the outset I must also say that much of this depends on whether or not the Bharatiya Janata Party (BJP)-led Centre adopts a liberal fiscal view towards an ongoing health crisis and the economic impact it entails.

The novel coronavirus COVID-19 has created havoc with Kerala’s economy at a time when the state is limping back to normalcy after two consecutive state-wide floods in 2018 and 2019. A few months before the 2018 flood, there was first Okhi cyclone and then the Nipah virus outbreak in parts of the state. Despite these setbacks, the economy proved to be resilient because remittances from Non-Resident Keralites in Gulf (West Asia) did not decline. This year I fear that is not happening, and the state’s revenues have sharply gone down.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show